1-6 of 6
Jieqiong Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment outcomes in patients with newly diagnosed multiple myeloma receiving ixazomib as initial therapy: A retrospective, observational, real-world historical database analysis from China

Free
Gang An, Jieqiong Zhou, Yuntong Liu, Wenqiang Yan, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2246.
https://doi.org/10.1182/blood-2025-2246
Published: 2025
Journal Articles

Circulating tumor plasma cells as an independent prognostic marker in newly diagnosed multiple myeloma: Clinical correlation and immunophenotypic insights

Free
Yating Li, Yuntong Liu, Jieqiong Zhou, Wenqiang Yan, Jian Cui, Jingyu Xu, Chenxing Du, Shuhui Deng, Yan Xu, Lugui Qiu, Gang An
Journal: Blood
Blood (2025) 146 (Supplement 1): 5761.
https://doi.org/10.1182/blood-2025-5761
Published: 2025
Journal Articles

Ixazomib combined with daratumumab-based regimens as first-line therapy for transplant-ineligible patients with newly diagnosed multiple myeloma: A real-world historical database analysis from China

Free
Jieqiong Zhou, Gang An, Yuntong Liu, Wenqiang Yan, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 8142.
https://doi.org/10.1182/blood-2025-8142
Published: 2025
Journal Articles

Dynamic changes in cytogenetic abnormalities during treatment predict long-term outcomes in multiple myeloma

Free
Jieqiong Zhou, Yuntong Liu, Gang An, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7542.
https://doi.org/10.1182/blood-2025-7542
Published: 2025
Journal Articles

Delayed and sustained minimal residual disease response predictsfavorable outcomes in newly diagnosed multiple myeloma

Free
Jieqiong Zhou, Yating Li, Gang An, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7536.
https://doi.org/10.1182/blood-2025-7536
Published: 2025
Journal Articles

In-class transition from bortezomib to ixazomib-based regimens in transplant-ineligible patients with newly diagnosed multiple myeloma: A retrospective, observational, real-world study conducted in China

Free
Jieqiong Zhou, Gang An, Yuntong Liu, Wenqiang Yan, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7550.
https://doi.org/10.1182/blood-2025-7550
Published: 2025